Arcturus Therapeutics Holdings Inc
50.01 - 56.56
8.51 - 129.71
Echofin Members Consensus
US Market US closed lower yesterday, amid concerns over economic recovery and as hopes for additional stimulus faded. Arcturus Therapeutics Holdings plunged 54.2%, as the company provided a disappointing update on its Covid-19 vaccine candidate, ARCT-021. Target lost 0.8%, after the company sold its Dermstore operation to THG Holdings for a cash consideration of $350.0 million. On the flipside, Snap jumped 6.2%, after a top broker raised its target price on the stock to $70.0 per share from $47.0 per share. Continental Resources advanced 1.7%, after a top broker upgraded its rating on the stock to ‘Overweight’ from ‘Sector Weight’. Bausch Health added 0.3%, after the drugmaker announced that it would pay down another $275.0 million in debt on 31 December 2020. Boeing rose 0.1%, as the airline operator resumed passenger flights in the US after a two-year halt. The S&P 500 slipped 0.2%, to settle at 3,727.0. The DJIA fell 0.2%, to settle at 30,335.7, while the NASDAQ shed 0.4%, to close at 12,850.2. .